` Comparison: 228760 vs VRTX - Alpha Spread

G
228760
vs
VRTX

Over the past 12 months, Genomictree Inc has outperformed VRTX, delivering a return of +21% compared to the VRTX's +2% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
228760
VRTX
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

Genomictree Inc Intrinsic Value
HIDDEN
Show
VRTX Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
G
Genomictree Inc
KOSDAQ:228760
22 450 KRW
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
477.7275 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
228760, VRTX

228760
VRTX
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
G
Genomictree Inc
Revenue
Vertex Pharmaceuticals Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
228760, VRTX

228760
VRTX
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
G
Genomictree Inc
KOSDAQ:228760
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

Genomictree Inc
20.1%
VRTX
86.3%

Operating Margin

Genomictree Inc
-328.3%
VRTX
38.7%

Net Margin

Genomictree Inc
-233.3%
VRTX
31.3%

FCF Margin

Genomictree Inc
-383.8%
VRTX
28.5%

ROE

Genomictree Inc
-7.3%
VRTX
22.3%

ROA

Genomictree Inc
-6.9%
VRTX
15.6%

ROIC

Genomictree Inc
-29.6%
VRTX
25.1%

ROCE

Genomictree Inc
-10.1%
VRTX
23.5%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
228760, VRTX

Loading
228760
VRTX
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
228760, VRTX

Performance Gap Between 228760 and VRTX
HIDDEN
Show

Performance By Year
228760, VRTX

Loading
228760
VRTX
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 228760 to other stocks
PNEXF
Pharnext SCA
ABBV
Abbvie Inc
AMGN
Amgen Inc
GILD
Gilead Sciences Inc
Custom
Choose any stock
Unlock Full Access to Alpha Spread
Create Free Account